We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
-27.56%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$1.77B
AUM Growth
-$1.21B
Cap. Flow
-$436M
Cap. Flow %
-24.67%
Top 10 Hldgs %
12.3%
Holding
1,254
New
453
Increased
136
Reduced
157
Closed
433

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$28.3M
2
TW icon
Tradeweb Markets
TW
+$11.9M
3
QURE icon
uniQure
QURE
+$10.5M
4
ON icon
ON Semiconductor
ON
+$7.63M
5
INST
Instructure, Inc.
INST
+$7.04M

Sector Composition

Rank Sector Weight
1 Healthcare 4.85%
2 Consumer Discretionary 4.41%
3 Technology 1.8%
4 Industrials 1.5%
5 Energy 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPLX icon
651
MPLX
MPLX
$59.3B
$283K 0.02%
+24,300
New +$498K
ET icon
652
Energy Transfer Partners
ET
$70.1B
$281K 0.02%
61,200
+13,200
+28% +$141K
PARA
653
PUT
DELISTED
Paramount Global Class B
PARA
$280K 0.02%
20,000
-50,000
-71% -$1.43M
SHW icon
654
Sherwin-Williams
SHW
$82.7B
$275K 0.02%
1,800
AMJ
655
CALL
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$274K 0.02%
+30,400
New +$531K
EVH icon
656
CALL
Evolent Health
EVH
$348M
$272K 0.02%
+50,000
New +$447K
UEIC icon
657
Universal Electronics
UEIC
$57.8M
$272K 0.02%
+7,100
New +$322K
RH icon
658
CALL
RH
RH
$3.13B
$271K 0.02%
+2,700
New +$503K
RH icon
659
PUT
RH
RH
$3.13B
$271K 0.02%
+2,700
New +$503K
ADNT icon
660
Adient
ADNT
$1.65B
$265K 0.02%
29,400
+16,500
+128% +$332K
LUMN icon
661
CALL
Lumen
LUMN
$6.57B
$265K 0.02%
28,000
MTDR icon
662
CALL
Matador Resources
MTDR
$6.2B
$264K 0.01%
+106,400
New +$1.17M
NERV icon
663
CALL
Minerva Neurosciences
NERV
$185M
$261K 0.01%
+5,438
New +$328K
LPX icon
664
Louisiana-Pacific
LPX
$5.06B
$257K 0.01%
+15,000
New +$415K
SGMO
665
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$255K 0.01%
40,000
-10,000
-20% -$74.2K
SGMO
666
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$255K 0.01%
40,000
+25,000
+167% +$186K
OCUL icon
667
CALL
Ocular Therapeutix
OCUL
$1.79B
$248K 0.01%
+50,000
New +$247K
ADVM
668
CALL
DELISTED
Adverum Biotechnologies
ADVM
$245K 0.01%
2,500
S
669
DELISTED
Sprint Corporation
S
$243K 0.01%
28,200
-189,900
-87% -$1.33M
DAC icon
670
CALL
Danaos Corp
DAC
$2.58B
$240K 0.01%
+60,000
New +$367K
INSM icon
671
Insmed
INSM
$21.4B
$240K 0.01%
15,000
-70,000
-82% -$1.66M
STAA icon
672
STAAR Surgical
STAA
$1.21B
$240K 0.01%
+7,461
New +$251K
CORT icon
673
Corcept Therapeutics
CORT
$12.4B
$237K 0.01%
20,000
-3,900
-16% -$48.3K
PI icon
674
Impinj
PI
$4.62B
$237K 0.01%
14,200
CMA
675
DELISTED
Comerica
CMA
$235K 0.01%
+8,000
New +$434K

Similar funds

Caption Management's Q1 2020 Portfolio in Review

As of Q1 2020, Caption Management held 1,254 positions worth $1.77B, down 41% from $2.98B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Caption Management withdrew a net $436M in Q1 2020, closing 433 positions and reducing 157 holdings. Its most notable exit was Medicines Co, an estimated $28.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 4.9% of assets, down from 5.7% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Caption Management opened a new position in Wayfair worth $7.62M.

  • Caption Management's largest Q1 2020 buy was Wayfair: 142,544 shares worth $7.62M.
  • Caption Management added most to GE Aerospace in Q1 2020, an estimated $8.43M increase.
  • Caption Management's biggest Q1 2020 reduction was uniQure, cutting an estimated $10.5M.
  • Caption Management fully exited Medicines Co in Q1 2020, selling an estimated $28.3M.
  • Caption Management's ten largest holdings make up 12% of its $1.77B portfolio in Q1 2020.
  • Caption Management opened 453 new positions and closed 433 in Q1 2020.
  • Caption Management's portfolio value fell 41% quarter-over-quarter to $1.77B.

Based on Caption Management's 13F filing for Q1 2020, filed 15 May 2020.